WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration.
It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022.
A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used.
Key moments from the arguments:
Related articles:
Related suggestion:
Real Madrid's Bellingham banned for two gamesProud of Motherland's AchievementsExperiencing Charm of Peking Opera While Cycling in BeijingTelling China's Story in Objective, Comprehensive WayExperiencing Charm of Peking Opera While Cycling in BeijingCreating Dream FarmChina clocks world's 2nd best time in men's 4x100m medley relay victory at Hangzhou Asiad2022 'She Can' Public Welfare Project Kicks off in ChengduBeijing Woman Turns Garbage into TreasureIndian cyclists David Beckham, Ronaldo catch eyes at Asiad
2.9357s , 6498.34375 kb
Copyright © 2024 Powered by 5 takeaways from the abortion pill case before the U.S. Supreme Court ,Global Glimpse news portal